Get a clear understanding of how compounds impact the metabolism with our in vivo expertise ranging from acute testing in mice and rats to chronic studies.

Read more

Improve the quality of your study endpoints by using histological and stereological analyses.

Read more

Let us transform complex big data into clear overviews enabling rapid decision making.

Read more

Tap into our vast experience with plasma and tissue biochemical, immuno-assays as well as model knowledge ensuring reproducible pre-clinical assay data packages.

Read more

Get access to our robust cellular assays for in vitro pharmacology and functional drug testing.

Read more

Benefit from our vast synthesis experience where we master a wide variety of chemistries as well as State-of-the-art solid-phase peptide methodologies.

Read more

“Gubra is a highly competent partner in execution of – also more complicated – preclinical studies. The long term experience and the deep scientific competence of Gubra partners adds value to the studies and is a guaranty for trustworthy results.“

Dr. Michael Mark
Vice President | Boehringer Ingelheim

NASH review

Review of preclinical models of NASH discussing the advantages and limitations of current in vivo mouse models used in drug discovery for NASH.
Read more  |  See other publications 

Press Release

Find out more about the partner program between Boeringer Ingelheim Pharma and Gubra.

Read more

Gubra Insights

Subscribe and get latest science insights from Gubra.

Sign up


Hørsholm Kongevej 11B
2970 Hørsholm
+45 3152 ­2650